Literature DB >> 12850554

The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3.

Georg C Terstappen1, Annalisa Pellacani, Laura Aldegheri, Francesca Graziani, Corrado Carignani, Giordano Pula, Caterina Virginio.   

Abstract

The effects of fluoxetine (Prozac) on the activity of human small-conductance calcium-activated potassium (SK) channels were investigated utilizing a functional fluorescence assay with bis-(1,3-dibutylbarbituric acid)trimethine oxonol (DiBAC(4)(3)). Fluoxetine blocked SK channels stably expressed in HEK 293 cells in a concentration-dependent manner displaying half-maximal inhibitory concentrations (IC(50)) of 9 microM for hSK1, 7 microM for hSK2 and 20 microM for hSK3. The block of hSK3 channels was confirmed by whole cell patch-clamp recordings of the recombinant cells and human TE 671 cells. Fluoxetine also inhibited [(125)I]apamin binding in a concentration-dependent manner displaying IC(50) values of 63 microM for hSK1, 148 microM for hSK2 and 295 microM for hSK3. These results provide new information concerning the mechanism of therapeutic and/or side effects of one of the most widely used antidepressant drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850554     DOI: 10.1016/s0304-3940(03)00574-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

Review 2.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

3.  Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.

Authors:  M B Madsen; L J A Kogelman; H N Kadarmideen; H B Rasmussen
Journal:  Pharmacogenomics J       Date:  2016-10-18       Impact factor: 3.550

Review 4.  The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.

Authors:  Charles Owen Smith; Keith Nehrke; Paul S Brookes
Journal:  Biochem J       Date:  2017-06-09       Impact factor: 3.857

Review 5.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 6.  Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain.

Authors:  P Pedarzani; M Stocker
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

7.  Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin.

Authors:  Anna L Vlasits; Julian A Simon; David W Raible; Edwin W Rubel; Kelly N Owens
Journal:  Hear Res       Date:  2012-08-31       Impact factor: 3.208

8.  Apical SK potassium channels and Ca2+-dependent anion secretion in endometrial epithelial cells.

Authors:  Melissa L Palmer; Katherine R Schiller; Scott M O'Grady
Journal:  J Physiol       Date:  2007-11-29       Impact factor: 5.182

Review 9.  Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation.

Authors:  Zoltan Ungvari; Stefano Tarantini; Andriy Yabluchanskiy; Anna Csiszar
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

Review 10.  Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Authors:  Deepanjali Dwivedi; Upinder S Bhalla
Journal:  Front Mol Neurosci       Date:  2021-06-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.